|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/65 | |
| A61K 9/08 | |||
| A61K 47/02 |
| (11) | Number of the document | 2568987 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11781314.7 |
| Date of filing the European patent application | 2011-05-12 | |
| (97) | Date of publication of the European application | 2013-03-20 |
| (45) | Date of publication and mention of the grant of the patent | 2016-11-16 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/036351 |
| Date | 2011-05-12 |
| (87) | Number | WO 2011/143503 |
| Date | 2011-11-17 |
| (30) | Number | Date | Country code |
| 392304 P | 2010-10-12 | US | |
| 334106 P | 2010-05-12 | US |
| (72) |
GRIFFITH, David C., US
BOYER, Serge, US
|
| (73) |
Rempex Pharmaceuticals, Inc.,
11535 Sorrento Valley Road, San Diego, CA 92121-1309,
US
|
| (54) | TETRACYCLINE COMPOSITIONS |
| TETRACYCLINE COMPOSITIONS |